ImmunoSupremo - I think a big plus for ABL is the length of time patients were on the drug durring BETonMACE, 6 to 36 months. Safe for cronic use I think were the words used. If we get an increase in cognitve function I think it will be a first historically. If that's the case it should at least raise a few eyebrows.
tada